NF1 and soft tissue sarcoma: Previous reports published by our group (2,27) demonstrated the regulation of microRNAs associated with several oncogenic pathways, including DICER1. Mutations in NF1 have already been demonstrated in soft-tissue sarcomas (myxofibrosarcomas and pleomorphic liposarcomas) (28).